Építés alatt – nem éles oldal
Belépés
BefejeződöttFázis nélkül

SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies (Level42)

A legfontosabb adatok

Ki végzi
The Geneva Foundation
Hol
Fort Sam Houston (Egyesült Államok)A helyszín megnézése
Azonosító
Állapot
Befejeződött
Résztvevők
300 fő vett részt
Kezdés
2023. máj. 15.
Befejezés
2026. márc. 30.
A vizsgálat típusa
Megfigyeléses, 2 csoport
A vizsgált kezelések
  • imPulse™ Systems (Una and TOR) infrasound-to-ultrasound e-stethoscope
A regiszteradat frissítve
2026. július 15.

Ki vehet részt

Életkor
18 év – 89 év
Nem
Nők és férfiak
Egészséges önkéntesek
Részt vehetnek

A regiszter feltételei, szó szerint

Mind a 7 feltétel megnézéseKevesebb

Ki vehet részt

  • Asymptomatic and symptomatic individuals 18 years and older
  • Receiving standard COVID-19, Flu, and/or RSV screening and testing at BAMC
  • Do not have to be diagnosed with SARS-CoV-19 (COVID-19), Flu, and/or RSV but only be screened
  • English Speaking

Ki nem vehet részt

  • Any individual under age of 18
  • Anyone unable to comply (or be assisted) with study procedures
  • Anyone not able to provide temperature thermal scan, and/or 3-minute vibroacoustic scan

Helyszínek itt: Egyesült Államok

  • Brooke Army Medical CenterFort Sam Houston, Egyesült Államok

A vizsgálatról

Mit akar kideríteni a vizsgálat

The goal of this observational study is to evaluate new non-invasive passive surveillance technologies, Level 42 AI imPulse™ Una and TOR devices for the detection of COVID-19, Flu, and/or RSV in asymptomatic and symptomatic individuals over age of 18 undergoing COVID-19, Flu, and/or RSV screening and testing at BAMC Ft Sam Houston, TX; with and without COVID-19, Flu, and/or RSV.

A teljes eredeti leírásKevesebb

The hypotheses are:

(H1) The imPulseTM Una and the imPulseTM TOR e-stethoscopes have at least a similar discriminative and detection ability among symptomatic and asymptomatic COVID-19 carrier versus those not infected compared to gold standard RT-PCR. We will operationalize and deploy both the imPulseTM Una and imPulseTM TOR e-stethoscope into DoD use-cases and compare their usability between the devices.

(H2) Identify if the imPulseTM Una and the imPulseTM TOR e-stethoscopes have at least a similar discriminative and detection ability among symptomatic and asymptomatic Respiratory Syncytial Virus (RSV), Influenza and Long COVID carriers versus those not infected compared to gold standard Rapid RSV and Flu Antigen Tests, or RT-PCR and molecular assays. We will operationalize and deploy both the imPulseTM Una and imPulseTM TOR e-stethoscope into DoD use-cases and compare their captured traces in the early identification of disease/illness analyzed by the devices built in algorithms.

(H3) In the mid to long-term, this approach will also be explored as a diagnostic system to explore pursue the physical (structural and mechanical) properties of cells and tissues that maintain normal cell behavior (motility, growth, apoptosis), and the critical importance of the ability of cells to sense and respond to mechanical stresses, which will be operationally critical for assessment of both traumatic and unconventional exposures in austere environments.

Participants will:

* Be consented; * Be screened for COVID-19, Flu, and/or RSV symptoms according to BAMC's current screening procedures; * Have study data collected; * Complete a symptoms questionnaire; * imPulseTM Una and TOR e-stethoscopes examination will be conducted; * Participants will be compensated for completing all study requirements. (Active-Duty personnel must complete the study procedures while off-duty in order to receive compensation.)

A vizsgálat 2 csoportja

  • COVID-19, Flu, and/or RSV positive patients

    Participants screened with known COVID-19, Flu, and/or RSV positive test results obtained within 48hrs of recruitment.

    Kezelés: imPulse™ Systems (Una and TOR) infrasound-to-ultrasound e-stethoscope

  • COVID-19, Flu, and/or RSV negative patients

    Participants screened with known COVID-19, Flu, and/or RSV negative test results obtained within 48hrs of recruitment.

    Kezelés: imPulse™ Systems (Una and TOR) infrasound-to-ultrasound e-stethoscope

Adatok és források

Regiszteradat
Szerepel a ClinicalTrials.gov-on.
Hivatalos cím
SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies
A regiszteradat frissítve
2026. július 15.